Gene Identification Tools Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

 2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Gene Identification Tools Market 

5.1. COVID-19 Landscape: Gene Identification Tools Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Gene Identification Tools Market, By Technology / Platform Type

8.1. Gene Identification Tools Market Revenue and Volume, by Technology / Platform Type

8.1.1. Sequencing Technologies (NGS, Sanger, Third-Generation)

8.1.1.1. Market Revenue and Volume Forecast  

8.1.2. Microarrays / Gene Expression Arrays

8.1.2.1. Market Revenue and Volume Forecast  

8.1.3. Hybrid Capture & Enrichment Panels

8.1.3.1. Market Revenue and Volume Forecast  

8.1.4. PCR-based Methods (qPCR, ddPCR, RT-PCR)

8.1.4.1. Market Revenue and Volume Forecast  

8.1.5. CRISPR / Gene Editing Screening Tools

8.1.5.1. Market Revenue and Volume Forecast  

8.1.6. Bioinformatics / Software Tools (gene prediction, annotation, variant calling)

8.1.6.1. Market Revenue and Volume Forecast  

Chapter 9. Global Gene Identification Tools Market, By Application Area

9.1. Gene Identification Tools Market Revenue and Volume, by Application Area

9.1.1. Clinical Diagnostics (rare disease, cancer panels)

9.1.1.1. Market Revenue and Volume Forecast  

9.1.2. Research & Functional Genomics

9.1.2.1. Market Revenue and Volume Forecast  

9.1.3. Agriculture & Animal Genomics

9.1.3.1. Market Revenue and Volume Forecast  

9.1.4. Pharmaceutical / Drug Discovery

9.1.4.1. Market Revenue and Volume Forecast  

9.1.5. Forensics & Ancestry

9.1.5.1. Market Revenue and Volume Forecast  

Chapter 10. Global Gene Identification Tools Market, By End-User

10.1. Gene Identification Tools Market Revenue and Volume, by End-User

10.1.1. Academic & Research Institutions

10.1.1.1. Market Revenue and Volume Forecast  

10.1.2. Hospitals & Clinical Laboratories

10.1.2.1. Market Revenue and Volume Forecast  

10.1.3. Biotechnology & Pharmaceutical Companies

10.1.3.1. Market Revenue and Volume Forecast  

10.1.4. Agriculture & Construction

10.1.4.1. Market Revenue and Volume Forecast  

10.1.5. Agricultural / Agri-Tech Firms

10.1.5.1. Market Revenue and Volume Forecast  

10.1.6. Contract Research Organizations (CROs)

10.1.6.1. Market Revenue and Volume Forecast  

Chapter 11. Global Gene Identification Tools Market, By Product / Service Offering

11.1. Gene Identification Tools Market Revenue and Volume, by Product / Service Offering

11.1.1. Kits & Reagents (library prep, probes, primers)

11.1.1.1. Market Revenue and Volume Forecast  

11.1.2. Instruments / Platforms (sequencers, PCR machines

11.1.2.1. Market Revenue and Volume Forecast  

11.1.3. Software & Analytics (variant calling, annotation, interpretation)

11.1.3.1. Market Revenue and Volume Forecast  

11.1.4. Services (gene discovery, sequencing services, custom panels)

11.1.4.1. Market Revenue and Volume Forecast  

Chapter 12. Global Gene Identification Tools Market, By Gene Type Targeted

12.1. Gene Identification Tools Market Revenue and Volume, by Gene Type Targeted

12.1.1. Coding Genes / Exons

12.1.1.1. Market Revenue and Volume Forecast  

12.1.2. Non-coding RNAs (miRNA, lncRNA)

12.1.2.1. Market Revenue and Volume Forecast  

12.1.3. Regulatory Regions (promoters, enhancrs)

12.1.3.1. Market Revenue and Volume Forecast  

12.1.4. Whole-Genome / Whole-Transcriptome

12.1.4.1. Market Revenue and Volume Forecast  

Chapter 13. Global Gene Identification Tools Market, By Species / Sample Type

13.1. Gene Identification Tools Market Revenue and Volume, by Species / Sample Type

13.1.1. Human / Clinical Samples

13.1.1.1. Market Revenue and Volume Forecast  

13.1.2. Model Organisms (mouse, fly, zebrafish)

13.1.2.1. Market Revenue and Volume Forecast  

13.1.3. Plant Genomics / Crop Species

13.1.3.1. Market Revenue and Volume Forecast  

13.1.3. Animal Genomics / Livestock

13.1.3.1. Market Revenue and Volume Forecast  

13.1.3. Environmental / Metagenomics Samples

13.1.3.1. Market Revenue and Volume Forecast  

Chapter 14. Global Gene Identification Tools Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.1.2. Market Revenue and Volume Forecast, by Application Area  

14.1.3. Market Revenue and Volume Forecast, by End-User  

14.1.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.1.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.1.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.1.7. U.S.

14.1.7.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.1.7.2. Market Revenue and Volume Forecast, by Application Area  

14.1.7.3. Market Revenue and Volume Forecast, by End-User  

14.1.7.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.1.8. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.1.8.1. Market Revenue and Volume Forecast, by Species / Sample Type   

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.1.9.2. Market Revenue and Volume Forecast, by Application Area  

14.1.9.3. Market Revenue and Volume Forecast, by End-User  

14.1.9.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.1.10. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.1.11. Market Revenue and Volume Forecast, by Species / Sample Type  

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.2.2. Market Revenue and Volume Forecast, by Application Area  

14.2.3. Market Revenue and Volume Forecast, by End-User  

14.2.4. Market Revenue and Volume Forecast, by Product / Service Offering   

14.2.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.2.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.2.8.2. Market Revenue and Volume Forecast, by Application Area  

14.2.8.3. Market Revenue and Volume Forecast, by End-User  

14.2.9. Market Revenue and Volume Forecast, by Product / Service Offering   

14.2.10. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.2.10.1. Market Revenue and Volume Forecast, by Species / Sample Type   

14.2.11. Germany

14.2.11.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.2.11.2. Market Revenue and Volume Forecast, by Application Area  

14.2.11.3. Market Revenue and Volume Forecast, by End-User  

14.2.12. Market Revenue and Volume Forecast, by Product / Service Offering  

14.2.13. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.2.14. Market Revenue and Volume Forecast, by Species / Sample Type  

14.2.15. France

14.2.15.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.2.15.2. Market Revenue and Volume Forecast, by Application Area  

14.2.15.3. Market Revenue and Volume Forecast, by End-User  

14.2.15.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.2.16. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.2.16.1. Market Revenue and Volume Forecast, by Species / Sample Type  

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.2.17.2. Market Revenue and Volume Forecast, by Application Area  

14.2.17.3. Market Revenue and Volume Forecast, by End-User  

14.2.17.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.2.18. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.2.18.1. Market Revenue and Volume Forecast, by Species / Sample Type  

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.3.2. Market Revenue and Volume Forecast, by Application Area  

14.3.3. Market Revenue and Volume Forecast, by End-User  

14.3.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.3.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.3.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.3.7. India

14.3.7.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.3.7.2. Market Revenue and Volume Forecast, by Application Area  

14.3.7.3. Market Revenue and Volume Forecast, by End-User  

14.3.7.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.3.8. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.3.9. Market Revenue and Volume Forecast, by Species / Sample Type  

14.3.10. China

14.3.10.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.3.10.2. Market Revenue and Volume Forecast, by Application Area  

14.3.10.3. Market Revenue and Volume Forecast, by End-User  

14.3.10.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.3.11. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.3.11.1. Market Revenue and Volume Forecast, by Species / Sample Type  

14.3.12. Japan

14.3.12.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.3.12.2. Market Revenue and Volume Forecast, by Application Area  

14.3.12.3. Market Revenue and Volume Forecast, by End-User  

14.3.12.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.3.12.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.3.12.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.3.13.2. Market Revenue and Volume Forecast, by Application Area  

14.3.13.3. Market Revenue and Volume Forecast, by End-User  

14.3.13.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.3.13.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.3.13.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.4.2. Market Revenue and Volume Forecast, by Application Area  

14.4.3. Market Revenue and Volume Forecast, by End-User  

14.4.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.4.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.4.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.4.7. GCC

14.4.7.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.4.7.2. Market Revenue and Volume Forecast, by Application Area  

14.4.7.3. Market Revenue and Volume Forecast, by End-User  

14.4.7.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.4.8. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.4.9. Market Revenue and Volume Forecast, by Species / Sample Type  

14.4.10. North Africa

14.4.10.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.4.10.2. Market Revenue and Volume Forecast, by Application Area  

14.4.10.3. Market Revenue and Volume Forecast, by End-User  

14.4.10.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.4.11. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.4.12. Market Revenue and Volume Forecast, by Species / Sample Type  

14.4.13. South Africa

14.4.13.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.4.13.2. Market Revenue and Volume Forecast, by Application Area  

14.4.13.3. Market Revenue and Volume Forecast, by End-User  

14.4.13.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.4.13.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.4.13.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.4.14.2. Market Revenue and Volume Forecast, by Application Area  

14.4.14.3. Market Revenue and Volume Forecast, by End-User  

14.4.14.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.4.14.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.4.14.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.5.2. Market Revenue and Volume Forecast, by Application Area  

14.5.3. Market Revenue and Volume Forecast, by End-User  

14.5.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.5.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.5.6. Market Revenue and Volume Forecast, by Species / Sample Type  

14.5.7. Brazil

14.5.7.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.5.7.2. Market Revenue and Volume Forecast, by Application Area  

14.5.7.3. Market Revenue and Volume Forecast, by End-User  

14.5.7.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.5.8. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.5.8.1. Market Revenue and Volume Forecast, by Species / Sample Type  

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Technology / Platform Type  

14.5.9.2. Market Revenue and Volume Forecast, by Application Area  

14.5.9.3. Market Revenue and Volume Forecast, by End-User  

14.5.9.4. Market Revenue and Volume Forecast, by Product / Service Offering  

14.5.9.5. Market Revenue and Volume Forecast, by Gene Type Targeted  

14.5.9.6. Market Revenue and Volume Forecast, by Species / Sample Type  

Chapter 15. Company Profiles

15.1. Thermo Fisher Scientific

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Illumina

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Genomatix (a subsidiary of Intrexon)

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Qiagen

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. BGI Genomics

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Roche

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Geneious

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. SoftGenetics

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. GenScript

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. DNASTAR

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms